A Study to Examine the Efficacy and Safety of Meridia® (Sibutramine Hydrochloride) in Binge-Eating Disorder
Clinical trial NCT00402584 · COMPLETED
Trial details
- NCT number
- NCT00402584
- Sponsor
- Abbott
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-08-01
- Enrollment
- 304
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.